BES_Mark.jpg
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Revance, Paysafe, Organogenesis, and Cloopen Group and Encourages Investors to Contact the Firm
February 07, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Revance, Shattuck Labs, and Standard Lithium and Encourages Investors to Contact the Firm
February 02, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sleep Number, Revance, Paysafe, and Organogenesis and Encourages Investors to Contact the Firm
January 28, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Revance Therapeutics, Cloopen Group, Exicure, and Sleep Number and Encourages Investors to Contact the Firm
January 23, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, Jan. 23, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important February 8 Deadline in Securities Class Action – RVNC
January 22, 2022 11:10 ET | The Rosen Law Firm PA
NEW YORK, Jan. 22, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Paysafe, Revance Therapeutics, and Cloopen Group and Encourages Investors to Contact the Firm
January 17, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Organogenesis, Paysafe, Revance Therapeutics, and Cloopen Group and Encourages Investors to Contact the Firm
January 09, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Paysafe, Revance, Cloopen Group, and Exicure and Encourages Investors to Contact the Firm
January 04, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING LAW FIRM, Encourages Revance Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important February 8 Deadline in Securities Class Action – RVNC
December 28, 2021 14:54 ET | The Rosen Law Firm PA
NEW YORK, Dec. 28, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between November...
BES_Mark.jpg
REVANCE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Revance Therapeutics, Inc. and Encourages Investors to Contact the Firm
December 24, 2021 21:00 ET | Bragar Eagel & Squire
NEW YORK, Dec. 24, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...